Victor Blanchette is Medical Director of the Paediatric Thrombosis and Haemostasis Programme in the Division of Haematology/Oncology at the Hospital for Sick Children, Toronto, and Medical Director of the SickKids-Caribbean Pediatric Cancer and Blood Disorders Initiative (SCI). He is also Professor of Pediatrics at the University of Toronto, Canada, where he is a Senior Associate Scientist in the Research Institute and a Clinician Investigator in the Department of Paediatrics.
Dr Blanchette received his medical training at the University of Cambridge and St Bartholomew’s Hospital in the United Kingdom. His postgraduate medical training included a paediatric residency at Johns Hopkins Hospital in the USA and a fellowship in paediatric haematology/oncology at McMaster University Medical Centre in Hamilton, Canada.
His research interests are in the area of inherited and acquired bleeding disorders of children. He is Director of the Paediatric Haemophilia Comprehensive Care Programme at the Hospital for Sick Children, and is a member of the Factor Prophylaxis Subcommittee of the Association of the Hemophilia Clinic Directors of Canada (AHCDC).
Dr Blanchette is Chair of the Canadian Paediatric Thrombosis and Hemostasis Network and a founding member of an Intercontinental Immune Thrombocytopenic Purpura (ITP) Study Group. He is Chair of the International Prophylaxis Study Group (the IPSG).
Dr Blanchette is an elected fellow of the Royal College of Physicians and Surgeons of the United Kingdom.
